This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Search results
From Proteopedia
You searched for Repurposing
There is no page with the exact title "Repurposing". The search results for "Repurposing" are displayed below. You can create a page titled Repurposing (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Drug repurposing (47 bytes)
1: List of pages with the keyword Drug repurposing - Category:Repurposing (42 bytes)
1: List of pages with the keyword Repurposing
Page text matches
- 8w4q (5,023 bytes)
16: ..., these results highlight the utility of the drug repurposing in combination with structure-based drug design i...
18: Drug repurposing and structure-based discovery of new PDE4 and PDE... - 8w4r (5,049 bytes)
16: ..., these results highlight the utility of the drug repurposing in combination with structure-based drug design i...
18: Drug repurposing and structure-based discovery of new PDE4 and PDE... - 8w4s (4,130 bytes)
14: ..., these results highlight the utility of the drug repurposing in combination with structure-based drug design i...
16: Drug repurposing and structure-based discovery of new PDE4 and PDE... - 8w4t (4,138 bytes)
14: ..., these results highlight the utility of the drug repurposing in combination with structure-based drug design i...
16: Drug repurposing and structure-based discovery of new PDE4 and PDE... - 4ij1 (4,212 bytes)
16: Repurposing the chemical scaffold of the anti-arthritic drug ... - 4cyr (4,364 bytes)
13: ...an altering the catalytic machinery, evolutionary repurposing was achieved by fine-tuning the molecular recogni...
15: Evolutionary repurposing of a sulfatase: A new Michaelis complex leads to ... - 4cys (4,647 bytes)
14: ...an altering the catalytic machinery, evolutionary repurposing was achieved by fine-tuning the molecular recogni...
16: Evolutionary repurposing of a sulfatase: A new Michaelis complex leads to ... - 2xuc (4,276 bytes)
14: ...lant-type family 18 chitinase inhibitors from the repurposing of a natural product. - 2xvp (3,629 bytes)
14: ...lant-type family 18 chitinase inhibitors from the repurposing of a natural product. - 2xvn (4,215 bytes)
14: ...lant-type family 18 chitinase inhibitors from the repurposing of a natural product. - 8ev1 (7,450 bytes)
14: ...ned ligand-based and structure-based multi-target repurposing strategy and applied it to a series of hexahydroc... - 8ev2 (7,422 bytes)
14: ...ned ligand-based and structure-based multi-target repurposing strategy and applied it to a series of hexahydroc... - 8bdy (5,053 bytes)
16: ...own co-crystalised ligands, we applied a scaffold-repurposing strategy for the identification of TRIM33 ligands...
18: Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase ... - 8bd9 (5,053 bytes)
16: ...own co-crystalised ligands, we applied a scaffold-repurposing strategy for the identification of TRIM33 ligands...
18: Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase ... - 8bd8 (5,052 bytes)
16: ...own co-crystalised ligands, we applied a scaffold-repurposing strategy for the identification of TRIM33 ligands...
18: Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase ... - 4m0r (4,268 bytes)
16: Repurposing the chemical scaffold of the anti-arthritic drug ... - 4m7u (4,367 bytes)
14: ...addressing bacterial resistance to antibiotics by repurposing a well-established classic antimicrobial target, ... - 4m7v (4,531 bytes)
14: ...addressing bacterial resistance to antibiotics by repurposing a well-established classic antimicrobial target, ... - 8fx3 (4,804 bytes)
14: ... TcHGXPRT with nanomolar affinity, validating the repurposing of TSAIs to expedite the discovery of lead compou...
16: ...e-Guanine-Xanthine Phosphoribosyltransferases and Repurposing of Transition-State Analogue Inhibitors.,Glockzin... - 4olc (3,904 bytes)
14: ... approved drug, is a promising candidate for drug repurposing.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
